lsi inds - LYTS
LYTS
Close Chg Chg %
19.00 -0.22 -1.16%
Closed Market
18.78
-0.22 (1.16%)
Volume: 87.98K
Last Updated:
Dec 26, 2025, 4:00 PM EDT
Company Overview: lsi inds - LYTS
LYTS Key Data
| Open $19.01 | Day Range 18.64 - 19.02 |
| 52 Week Range 13.77 - 25.49 | Market Cap $590.76M |
| Shares Outstanding 31.09M | Public Float 27.14M |
| Beta 0.18 | Rev. Per Employee N/A |
| P/E Ratio 23.64 | EPS $0.83 |
| Yield 105.26% | Dividend $0.05 |
| EX-DIVIDEND DATE Nov 17, 2025 | SHORT INTEREST N/A |
| AVERAGE VOLUME 132.64K |
LYTS Performance
| 1 Week | 1.57% | ||
| 1 Month | 2.68% | ||
| 3 Months | -20.73% | ||
| 1 Year | -3.35% | ||
| 5 Years | 120.42% |
LYTS Analyst Ratings
- Sell
- Under
- Hold
- Over
- Buy
Number of Ratings
4
Full Ratings ➔
About lsi inds - LYTS
LSI Industries Inc. engages in the provision of lighting and retail display solutions. It operates through the Lighting and Display Solutions segments. The Lighting segment manufactures and markets outdoor and indoor lighting for the commercial, industrial and multi-site retail markets, including the petroleum or convenience store market. The Display Solutions segment fabricates and sells exterior and interior visual image elements related to graphics. The company was founded by Robert J. Ready, James P. Sferra, and Donald E. Whipple in 1976 and is headquartered in Cincinnati, OH.
LYTS At a Glance
LSI Industries, Inc.
10000 Alliance Road
Cincinnati, Ohio 45242
| Phone | 1-513-793-3200 | Revenue | 573.38M | |
| Industry | Building Products | Net Income | 24.38M | |
| Sector | Producer Manufacturing | 2025 Sales Growth | 22.089% | |
| Fiscal Year-end | 06 / 2026 | Employees | 2,175 | |
| View SEC Filings |
LYTS Valuation
| P/E Current | 23.644 |
| P/E Ratio (with extraordinary items) | N/A |
| P/E Ratio (without extraordinary items) | 21.51 |
| Price to Sales Ratio | 0.915 |
| Price to Book Ratio | 2.216 |
| Price to Cash Flow Ratio | 13.76 |
| Enterprise Value to EBITDA | 11.826 |
| Enterprise Value to Sales | 1.025 |
| Total Debt to Enterprise Value | 0.113 |
LYTS Efficiency
| Revenue/Employee | 263,621.609 |
| Income Per Employee | 11,210.575 |
| Receivables Turnover | 5.495 |
| Total Asset Turnover | 1.539 |
LYTS Liquidity
| Current Ratio | 1.995 |
| Quick Ratio | 1.175 |
| Cash Ratio | 0.036 |
LYTS Profitability
| Gross Margin | 24.766 |
| Operating Margin | 6.473 |
| Pretax Margin | 5.762 |
| Net Margin | 4.253 |
| Return on Assets | 6.544 |
| Return on Equity | 11.209 |
| Return on Total Capital | 8.20 |
| Return on Invested Capital | 8.792 |
LYTS Capital Structure
| Total Debt to Total Equity | 28.884 |
| Total Debt to Total Capital | 22.411 |
| Total Debt to Total Assets | 16.813 |
| Long-Term Debt to Equity | 24.719 |
| Long-Term Debt to Total Capital | 19.18 |
- Income Statement
- Balance Sheet
- Cash Flow Statement
Annual Financials for Lsi Inds - LYTS
Collapse All in section
| All values USD millions. | 2022 | 2023 | 2024 | 2025 | 5-year trend |
|---|---|---|---|---|---|
Sales/Revenue
| 455.12M | 496.98M | 469.64M | 573.38M | |
Sales Growth
| +44.20% | +9.20% | -5.50% | +22.09% | |
Cost of Goods Sold (COGS) incl D&A
| 345.91M | 360.00M | 335.96M | 431.37M | |
COGS excluding D&A
| - | - | - | - | - |
Depreciation & Amortization Expense
| 10.12M | 9.66M | 10.00M | 12.57M | |
Depreciation
| 5.31M | 4.90M | 5.04M | 6.77M | |
Amortization of Intangibles
| 4.81M | 4.76M | 4.96M | 5.81M | |
COGS Growth
| +46.18% | +4.07% | -6.68% | +28.40% | |
Gross Income
| 109.21M | 136.98M | 133.68M | 142.00M | |
Gross Income Growth
| +38.28% | +25.43% | -2.41% | +6.23% | |
Gross Profit Margin
| +24.00% | +27.56% | +28.46% | +24.77% |
| 2022 | 2023 | 2024 | 2025 | 5-year trend | |
|---|---|---|---|---|---|
SG&A Expense
| 87.52M | 99.88M | 96.62M | 104.89M | |
Research & Development
| 3.60M | 3.40M | 3.50M | 3.30M | |
Other SG&A
| 83.92M | 96.48M | 93.12M | 101.59M | |
SGA Growth
| +28.75% | +14.12% | -3.27% | +8.56% | |
Other Operating Expense
| - | - | - | - | - |
Unusual Expense
| 485.00K | 66.00K | 1.54M | 1.35M | |
EBIT after Unusual Expense
| 21.20M | 37.03M | 35.52M | 35.77M | |
Non Operating Income/Expense
| (148.00K) | (15.00K) | (262.00K) | 398.00K | |
Non-Operating Interest Income
| - | - | - | - | - |
Equity in Earnings of Affiliates
| - | - | - | - | - |
Interest Expense
| 1.97M | 3.69M | 2.16M | 3.13M | |
Interest Expense Growth
| +585.71% | +87.35% | -41.52% | +45.13% | |
Gross Interest Expense
| 1.97M | 3.69M | 2.16M | 3.13M | |
Interest Capitalized
| - | - | - | - | - |
Pretax Income
| 19.09M | 33.33M | 33.10M | 33.04M | |
Pretax Income Growth
| +141.09% | +74.62% | -0.68% | -0.18% | |
Pretax Margin
| +4.19% | +6.71% | +7.05% | +5.76% | |
Income Tax
| 4.05M | 7.56M | 8.12M | 8.65M | |
Income Tax - Current - Domestic
| 4.23M | 7.66M | 9.76M | 10.34M | |
Income Tax - Current - Foreign
| 165.00K | 325.00K | (30.00K) | 700.00K | |
Income Tax - Deferred - Domestic
| (342.00K) | (418.00K) | (1.61M) | (2.38M) | |
Income Tax - Deferred - Foreign
| - | - | - | - | - |
Income Tax Credits
| - | - | - | - | - |
Equity in Earnings of Affiliates
| - | - | - | - | - |
Other After Tax Income (Expense)
| - | - | - | - | - |
Consolidated Net Income
| 15.03M | 25.76M | 24.98M | 24.38M | |
Minority Interest Expense
| - | - | - | - | - |
Net Income
| 15.03M | 25.76M | 24.98M | 24.38M | |
Net Income Growth
| +156.17% | +71.38% | -3.05% | -2.38% | |
Net Margin Growth
| +3.30% | +5.18% | +5.32% | +4.25% | |
Extraordinaries & Discontinued Operations
| - | - | - | - | - |
Discontinued Operations
| - | - | - | - | - |
Net Income After Extraordinaries
| 15.03M | 25.76M | 24.98M | 24.38M | |
Preferred Dividends
| - | - | - | - | - |
Net Income Available to Common
| 15.03M | 25.76M | 24.98M | 24.38M | |
EPS (Basic)
| 0.5509 | 0.9159 | 0.8598 | 0.8154 | |
EPS (Basic) Growth
| +150.64% | +66.26% | -6.13% | -5.16% | |
Basic Shares Outstanding
| 27.29M | 28.13M | 29.05M | 29.90M | |
EPS (Diluted)
| 0.537 | 0.8788 | 0.8307 | 0.7908 | |
EPS (Diluted) Growth
| +151.17% | +63.65% | -5.47% | -4.80% | |
Diluted Shares Outstanding
| 27.99M | 29.32M | 30.07M | 30.83M | |
EBITDA
| 31.80M | 46.76M | 47.06M | 49.69M | |
EBITDA Growth
| +66.14% | +47.02% | +0.64% | +5.60% | |
EBITDA Margin
| +6.99% | +9.41% | +10.02% | +8.67% |
Snapshot
| Average Recommendation | BUY | Average Target Price | 27.00 | |
| Number of Ratings | 4 | Current Quarters Estimate | 0.203 | |
| FY Report Date | 12 / 2025 | Current Year's Estimate | 1.11 | |
| Last Quarter’s Earnings | 0.31 | Median PE on CY Estimate | N/A | |
| Year Ago Earnings | 1.07 | Next Fiscal Year Estimate | 1.37 | |
| Median PE on Next FY Estimate | N/A |
Earnings Per Share
| This Quarter | Next Quarter | This Fiscal | Next Fiscal | |
|---|---|---|---|---|
| # of Estimates | 4 | 4 | 4 | 4 |
| Mean Estimate | 0.20 | 0.22 | 1.11 | 1.37 |
| High Estimates | 0.22 | 0.26 | 1.19 | 1.51 |
| Low Estimate | 0.17 | 0.12 | 0.95 | 1.30 |
| Coefficient of Variance | 10.95 | 30.38 | 9.76 | 7.23 |
Analysts Recommendations
| Current | 1 Month Ago | 3 Months Ago | |
|---|---|---|---|
| BUY | 4 | 4 | 4 |
| OVERWEIGHT | 0 | 0 | 0 |
| HOLD | 0 | 0 | 0 |
| UNDERWEIGHT | 0 | 0 | 0 |
| SELL | 0 | 0 | 0 |
| MEAN | Buy | Buy | Buy |
SEC Filings for Lsi Inds - LYTS
| Filing Date | Type | Category | Amended |
|---|---|---|---|
| No results | |||
Insider Actions for Lsi Inds - LYTS
| Date | Name | Shares | Transaction | Value |
|---|---|---|---|---|
| Sep 11, 2025 | James E. Galeese Executive VP; CFO | N/A | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 0.00 |
| Sep 11, 2025 | James E. Galeese Executive VP; CFO | N/A | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 0.00 |
| Sep 11, 2025 | James E. Galeese Executive VP; CFO | 173,288 | Open market or private sale of non-derivative or derivative security Non-derivative transaction at $23.29 per share | 4,035,877.52 |
| Sep 11, 2025 | James E. Galeese Executive VP; CFO | 194,989 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 Non-derivative transaction at $5.92 per share | 1,154,334.88 |
| Sep 11, 2025 | James E. Galeese Executive VP; CFO | 173,288 | Open market or private sale of non-derivative or derivative security Non-derivative transaction at $23.29 per share | 4,035,877.52 |
| Sep 11, 2025 | James E. Galeese Executive VP; CFO | 206,162 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 Non-derivative transaction at $9.15 per share | 1,886,382.30 |
| Aug 28, 2025 | Thomas A. Caneris Exec. VP, HR & General Counsel | 121,864 | Open market or private sale of non-derivative or derivative security Non-derivative transaction at $22.95 per share | 2,796,778.80 |
| Aug 28, 2025 | James A. Clark CEO and President; Director | 447,910 | Open market or private sale of non-derivative or derivative security Non-derivative transaction at $22.95 per share | 10,279,534.50 |
| Aug 28, 2025 | James A. Clark CEO and President; Director | 471,930 | Open market or private sale of non-derivative or derivative security Non-derivative transaction at $23.01 per share | 10,859,109.30 |
| Aug 28, 2025 | Thomas A. Caneris Exec. VP, HR & General Counsel | 121,560 | Bona fide gift Non-derivative transaction at $22.95 per share | 2,789,802.00 |
| Aug 28, 2025 | Thomas A. Caneris Exec. VP, HR & General Counsel | 128,319 | Open market or private sale of non-derivative or derivative security Non-derivative transaction at $23.01 per share | 2,952,620.19 |
| Jan 6, 2025 | Ernest W. Marshall Director | 16,019 | Grant, award or other acq pursuant to Rule 16b-3(d) Non-derivative transaction at $19.37 per share | 310,288.03 |
| Jan 6, 2025 | Amy L. Hanson Director | 61,363 | Grant, award or other acq pursuant to Rule 16b-3(d) Non-derivative transaction at $19.37 per share | 1,188,601.31 |
| Jan 6, 2025 | Robert Patterson Beech Director | 96,390 | Grant, award or other acq pursuant to Rule 16b-3(d) Non-derivative transaction at $19.37 per share | 1,867,074.30 |
| Jan 6, 2025 | Wilfred T. O'Gara Director | 116,552 | Grant, award or other acq pursuant to Rule 16b-3(d) Non-derivative transaction at $19.37 per share | 2,257,612.24 |
| Jan 6, 2025 | Ronald D. Brown Director | 68,612 | Grant, award or other acq pursuant to Rule 16b-3(d) Non-derivative transaction at $19.37 per share | 1,329,014.44 |
| Jan 6, 2025 | Chantel E. Lenard Director | 33,440 | Grant, award or other acq pursuant to Rule 16b-3(d) Non-derivative transaction at $19.37 per share | 647,732.80 |